| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 |
| filingDate |
1996-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1999-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H11508237-A |
| titleOfInvention |
Reversed phase fluorocarbon emulsion composition for drug delivery |
| abstract |
(57) Abstract A polar liquid-in-perfluorochemical emulsion or microemulsion for use in delivering therapeutic or diagnostic agents. These compositions are formed by combining a discontinuous aqueous phase, a continuous fluorocarbon phase, and a non-fluorinated surfactant. In addition, polar liquid in perfluorochemical emulsions can be used to form multiple emulsions having a continuous aqueous phase. Such emulsions and microemulsions are suitable for the administration of medicaments containing genetic material. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011520936-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006057429-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017517533-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101424516-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006500424-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9616131-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012073856-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007525554-A |
| priorityDate |
1995-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |